Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Pantoprazole may enhance antiplatelet effect of enteric-coated aspirin in patients with acute coronary syndrome.

Kasprzak M, Koziński M, Bielis L, Boinska J, Plazuk W, Marciniak A, Budzyński J, Siller-Matula J, Rość D, Kubica J.

Cardiol J. 2009;16(6):535-44.

2.

Indications for dual antiplatelet therapy with aspirin and clopidogrel: evidence-based recommendations for use.

Reaume KT, Regal RE, Dorsch MP.

Ann Pharmacother. 2008 Apr;42(4):550-7. doi: 10.1345/aph.1K433. Review.

PMID:
18319394
3.

[Prevention of GI bleeding due to antiplatelet agents: a labyrinth!].

Bretagne JF.

Presse Med. 2009 Dec;38(12):1722-6. doi: 10.1016/j.lpm.2009.09.011. Review. French. No abstract available.

PMID:
19914029
4.

Aspirin and clopidogrel hyporesponsiveness and nonresponsiveness in patients with coronary artery stenting.

Sharma RK, Reddy HK, Singh VN, Sharma R, Voelker DJ, Bhatt G.

Vasc Health Risk Manag. 2009;5:965-72. Review.

5.

Antiplatelet resistance--fact or myth?

Gurbel PA, Tantry US.

Am Heart Hosp J. 2009 Summer;7(1):50-7. Review. No abstract available.

PMID:
19742434
6.

Review article: proton pump inhibitors with clopidogrel--evidence for and against a clinically-important interaction.

Disney BR, Watson RD, Blann AD, Lip GY, Anderson MR.

Aliment Pharmacol Ther. 2011 Apr;33(7):758-67. doi: 10.1111/j.1365-2036.2011.04585.x. Review.

7.

Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials.

O'Donoghue ML, Braunwald E, Antman EM, Murphy SA, Bates ER, Rozenman Y, Michelson AD, Hautvast RW, Ver Lee PN, Close SL, Shen L, Mega JL, Sabatine MS, Wiviott SD.

Lancet. 2009 Sep 19;374(9694):989-97. doi: 10.1016/S0140-6736(09)61525-7. Review.

PMID:
19726078
8.

Aspirin in coronary artery disease: an appraisal of functions and limitations.

Würtz M.

Dan Med J. 2015 Apr;62(4):B5011. Review.

PMID:
25872543
9.

Role of antiplatelet therapy across the spectrum of patients with coronary artery disease.

Bhatt DL.

Am J Cardiol. 2009 Feb 2;103(3 Suppl):11A-19A. doi: 10.1016/j.amjcard.2008.11.018. Review.

PMID:
19166708
10.

Dual antiplatelet therapy in coronary artery disease: a case-based approach.

Raymond C, Menon V.

Cleve Clin J Med. 2009 Nov;76(11):663-70. doi: 10.3949/ccjm.76a.09045. Review.

11.
12.

Antiplatelet strategies: evaluating their current role in the setting of acute coronary syndromes.

Braunwald E, Angiolillo D, Bates E, Berger PB, Bhatt D, Cannon CP, Furman MI, Gurbel P, Michelson AD, Peterson E, Wiviott S.

Clin Cardiol. 2008 Mar;31(3 Suppl 1):I2-9. doi: 10.1002/clc.20362. Review. Erratum in: Clin Cardiol. 2009 Feb;32(2):111.

13.
14.

The rationale for and comparisons of different antiplatelet treatments in acute coronary syndrome.

Gurbel PA, Tantry US.

J Interv Cardiol. 2008 Dec;21 Suppl 1:S10-7. doi: 10.1111/j.1540-8183.2008.00408.x. Review.

PMID:
19090932
15.

Antiplatelet drug interactions with proton pump inhibitors.

Scott SA, Owusu Obeng A, Hulot JS.

Expert Opin Drug Metab Toxicol. 2014 Feb;10(2):175-89. doi: 10.1517/17425255.2014.856883. Review.

16.

Cytochrome allelic variants and clopidogrel metabolism in cardiovascular diseases therapy.

Jarrar M, Behl S, Manyam G, Ganah H, Nazir M, Nasab R, Moustafa K.

Mol Biol Rep. 2016 Jun;43(6):473-84. doi: 10.1007/s11033-016-3983-1. Review.

PMID:
27072373
17.

Monitoring the effectiveness of antiplatelet therapy: opportunities and limitations.

Sambu N, Curzen N.

Br J Clin Pharmacol. 2011 Oct;72(4):683-96. doi: 10.1111/j.1365-2125.2011.03955.x. Review.

18.

[Antiplatelet therapy in atherosclerosis of various localizations: acute and stable States].

Koziolova NA.

Kardiologiia. 2014;54(4):96-108. Review. Russian.

PMID:
25177792
19.

Almanac 2011: Acute coronary syndromes. The national society journals present selected research that has driven recent advances in clinical cardiology.

Knight CJ, Timmis AD.

Heart. 2011 Nov;97(22):1820-7. doi: 10.1136/heartjnl-2011-300979. Review. No abstract available.

PMID:
21948961
20.

Diclofenac- and Pantoprazole-Induced Rhabdomyolysis: A Potential Drug Interaction.

Ertekin YH, Yakar B, Ertekin H, Uludağ A, Tekin M.

Drug Saf Case Rep. 2015 Dec;2(1):10. Review.

Supplemental Content

Support Center